Dr Sharad Bellapravalu, MD | |
13400 E Shea Blvd, Scottsdale, AZ 85259-5499 | |
(480) 301-8000 | |
Not Available |
Full Name | Dr Sharad Bellapravalu |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 13400 E Shea Blvd, Scottsdale, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679688790 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 15291 (Arizona) | Secondary |
174400000X | Specialist | 15291 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sharad Bellapravalu, MD 13400 E Shea Blvd, Scottsdale, AZ 85259-5499 Ph: (480) 301-8000 | Dr Sharad Bellapravalu, MD 13400 E Shea Blvd, Scottsdale, AZ 85259-5499 Ph: (480) 301-8000 |
News Archive
InNexus Biotechnology Inc., a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company and the National Cancer Institute (NCI), part of the U.S. National Institutes of Health (NIH), have amended the Collaborative Agreement announced on May 27, 2010, involving research on technologies developed by InNexus.
In the first study of its type, researchers at the University of California, San Diego School of Medicine have looked at the health threat to pregnant women with a history of Kawasaki disease (KD), concluding that the risks are low with informed management and care.
In acknowledgement of this year's World Diabetes Day, which calls on all those responsible for diabetes care to understand diabetes and take control, Medtronic, Inc. (NYSE: MDT) highlights the growing body of clinical evidence for Personal Continuous Glucose Monitoring (CGM) in improving glucose control for diabetes patients.
A new platform for regulating the expression of therapeutic genes, which will have major implications for gene and cell therapy, was presented at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle.
› Verified 6 days ago